biotech
FISH-Based Test Identify Genetic Abnormalities in Plasma Cell Malignancies
Filed in archive Diagnostics, Methodologies and Instrumentation , Genomics, Proteomics and Bioinformatics by ruth on October 28, 2007
FISH-Based Test Identify Genetic Abnormalities in Plasma Cell Malignancies
Mayo Clinic researchers have developed a chromosome FISH-based test which surpasses conventional methods in identifying chromosomal genetic abnormalities associated with plasma cell malignancies and thus help physicians better assess a patient's prognosis and likelihood to respond to a given treatment. Plasma cell proliferative disorders, or PCPD, account for approximately 10 percent of all blood born cancers.
The FISH test is designed to detect genetic abnormalities in plasma cells whereas other conventional methods typically looks within any cell type that is present.

The test should be applied to patients diagnosed with PCPD, particularly multiple myeloma, to determine the presence of genetic abnormalities that could offer insight into prognosis, he states.


Source: Mayo Clinic

Permalink: FISH-Based Test Identify Genetic Abnormalities in Plasma Cell Malignancies
Tags: FISH  genetics  genomics  cancer  diagnostics  biotech  genetic+abnormalities  plasma+cell 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/99110
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for FISH-Based Test Identify Genetic Abnormalities in Plasma Cell Malignancies:

  • Currently 8.33/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 8.33 out of 6 vote(s) cast.
Subscribe
Share It
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!